Plasma proteomics in patients with von Willebrand disease and hemophilia A highlights von Willebrand factor as main determinant of response to desmopressin treatment
Background: Desmopressin, 1-deamino-8-D-arginin vasopressin (DDAVP), is a treatment option for people with von Willebrand disease (VWD) and hemophilia A (HA) with a large interindividual variation in response. DDAVP elicits the release of von Willebrand Factor (VWF) from endothelial cells, thereby i...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2025-03-01
|
| Serier: | Research and Practice in Thrombosis and Haemostasis |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S2475037925000627 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
